Annuncio • Jul 27
Aarti Surfactants Limited to Report Q1, 2027 Results on Aug 01, 2026 Aarti Surfactants Limited announced that they will report Q1, 2027 results at 4:00 PM, Indian Standard Time on Aug 01, 2026 Reported Earnings • May 11
Full year 2026 earnings released: EPS: ₹14.59 (vs ₹17.20 in FY 2025) Full year 2026 results: EPS: ₹14.59 (down from ₹17.20 in FY 2025). Revenue: ₹8.59b (up 30% from FY 2025). Net income: ₹123.4m (down 15% from FY 2025). Profit margin: 1.4% (down from 2.2% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 10% per year. Annuncio • May 04
Aarti Surfactants Limited to Report Q4, 2026 Results on May 09, 2026 Aarti Surfactants Limited announced that they will report Q4, 2026 results at 4:00 PM, Indian Standard Time on May 09, 2026 Buy Or Sell Opportunity • Apr 28
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 1.8% to ₹417. The fair value is estimated to be ₹341, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10.0% over the last 3 years, while earnings per share has been flat. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹377, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 38% over the past three years. New Risk • Jan 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.7x net interest cover). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (₹3.89b market cap, or US$42.8m). Reported Earnings • Jan 20
Third quarter 2026 earnings released: EPS: ₹4.32 (vs ₹0.95 in 3Q 2025) Third quarter 2026 results: EPS: ₹4.32 (up from ₹0.95 in 3Q 2025). Revenue: ₹2.08b (up 28% from 3Q 2025). Net income: ₹36.6m (up 359% from 3Q 2025). Profit margin: 1.8% (up from 0.5% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 8% per year, which means it is performing significantly worse than earnings. Annuncio • Jan 12
Aarti Surfactants Limited to Report Q3, 2026 Results on Jan 19, 2026 Aarti Surfactants Limited announced that they will report Q3, 2026 results on Jan 19, 2026 Reported Earnings • Nov 11
Second quarter 2026 earnings released: EPS: ₹1.84 (vs ₹2.13 in 2Q 2025) Second quarter 2026 results: EPS: ₹1.84 (down from ₹2.13 in 2Q 2025). Revenue: ₹1.79b (up 19% from 2Q 2025). Net income: ₹15.6m (down 14% from 2Q 2025). Profit margin: 0.9% (down from 1.2% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Annuncio • Nov 04
Aarti Surfactants Limited to Report Q2, 2026 Results on Nov 10, 2025 Aarti Surfactants Limited announced that they will report Q2, 2026 results on Nov 10, 2025 Upcoming Dividend • Sep 09
Upcoming dividend of ₹1.00 per share Eligible shareholders must have bought the stock before 16 September 2025. Payment date: 22 October 2025. Payout ratio is a comfortable 5.8% but the company is not cash flow positive. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.7%). Annuncio • Sep 02
Aarti Surfactants Limited Announces Annual Dividend, Payable on October 22, 2025 Aarti Surfactants Limited announced Annual dividend of INR 1.0000 per share payable on October 22, 2025, ex-date on September 16, 2025 and record date on September 16, 2025. Annuncio • Sep 01
Aarti Surfactants Limited, Annual General Meeting, Sep 23, 2025 Aarti Surfactants Limited, Annual General Meeting, Sep 23, 2025, at 16:00 Indian Standard Time. Valuation Update With 7 Day Price Move • Aug 12
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹469, the stock trades at a trailing P/E ratio of 26x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 38% over the past three years. Reported Earnings • Aug 06
First quarter 2026 earnings released: EPS: ₹3.48 (vs ₹2.62 in 1Q 2025) First quarter 2026 results: EPS: ₹3.48 (up from ₹2.62 in 1Q 2025). Revenue: ₹2.16b (up 51% from 1Q 2025). Net income: ₹29.4m (up 33% from 1Q 2025). Profit margin: 1.4% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Annuncio • Jul 30
Aarti Surfactants Limited to Report Q1, 2026 Results on Aug 05, 2025 Aarti Surfactants Limited announced that they will report Q1, 2026 results on Aug 05, 2025 Valuation Update With 7 Day Price Move • May 19
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to ₹622, the stock trades at a trailing P/E ratio of 36.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 10% over the past three years. Reported Earnings • May 13
Full year 2025 earnings released: EPS: ₹17.20 (vs ₹26.64 in FY 2024) Full year 2025 results: EPS: ₹17.20 (down from ₹26.64 in FY 2024). Revenue: ₹6.63b (up 12% from FY 2024). Net income: ₹145.4m (down 32% from FY 2024). Profit margin: 2.2% (down from 3.6% in FY 2024). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Annuncio • May 05
Aarti Surfactants Limited to Report Q4, 2025 Results on May 12, 2025 Aarti Surfactants Limited announced that they will report Q4, 2025 results on May 12, 2025 Valuation Update With 7 Day Price Move • Feb 15
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹495, the stock trades at a trailing P/E ratio of 44.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 42% over the past three years. New Risk • Feb 09
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.5% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.9x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.5% net profit margin). Market cap is less than US$100m (₹5.18b market cap, or US$59.1m). Reported Earnings • Feb 09
Third quarter 2025 earnings released: EPS: ₹0.95 (vs ₹8.42 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.95 (down from ₹8.42 in 3Q 2024). Revenue: ₹1.63b (up 17% from 3Q 2024). Net income: ₹7.98m (down 88% from 3Q 2024). Profit margin: 0.5% (down from 4.8% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Annuncio • Feb 01
Aarti Surfactants Limited to Report Q3, 2025 Results on Feb 08, 2025 Aarti Surfactants Limited announced that they will report Q3, 2025 results at 12:08 PM, Indian Standard Time on Feb 08, 2025 Reported Earnings • Nov 12
Second quarter 2025 earnings released: EPS: ₹2.13 (vs ₹5.97 in 2Q 2024) Second quarter 2025 results: EPS: ₹2.13 (down from ₹5.97 in 2Q 2024). Revenue: ₹1.53b (up 6.2% from 2Q 2024). Net income: ₹18.1m (down 62% from 2Q 2024). Profit margin: 1.2% (down from 3.3% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Annuncio • Nov 05
Aarti Surfactants Limited to Report Q2, 2025 Results on Nov 11, 2024 Aarti Surfactants Limited announced that they will report Q2, 2025 results on Nov 11, 2024 New Risk • Sep 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (43% net debt to equity). Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (6.7% increase in shares outstanding). Market cap is less than US$100m (₹7.63b market cap, or US$91.1m). Buy Or Sell Opportunity • Sep 17
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 33% to ₹900. The fair value is estimated to be ₹737, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has grown by 18%. Valuation Update With 7 Day Price Move • Sep 16
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹768, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 36x in the Chemicals industry in India. Total loss to shareholders of 47% over the past three years. Annuncio • Jul 24
Aarti Surfactants Limited, Annual General Meeting, Aug 14, 2024 Aarti Surfactants Limited, Annual General Meeting, Aug 14, 2024, at 11:00 Indian Standard Time. Reported Earnings • Jul 21
First quarter 2025 earnings released: EPS: ₹2.62 (vs ₹6.61 in 1Q 2024) First quarter 2025 results: EPS: ₹2.62 (down from ₹6.61 in 1Q 2024). Revenue: ₹1.44b (down 3.2% from 1Q 2024). Net income: ₹22.2m (down 58% from 1Q 2024). Profit margin: 1.5% (down from 3.5% in 1Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings. Annuncio • Jul 14
Aarti Surfactants Limited to Report Q1, 2025 Results on Jul 20, 2024 Aarti Surfactants Limited announced that they will report Q1, 2025 results at 12:08 PM, Indian Standard Time on Jul 20, 2024 New Risk • Apr 29
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks High level of debt (42% net debt to equity). Shareholders have been diluted in the past year (6.6% increase in shares outstanding). Market cap is less than US$100m (₹5.53b market cap, or US$66.3m). Reported Earnings • Apr 23
Full year 2024 earnings released: EPS: ₹26.63 (vs ₹16.64 in FY 2023) Full year 2024 results: EPS: ₹26.63 (up from ₹16.64 in FY 2023). Revenue: ₹5.90b (down 1.9% from FY 2023). Net income: ₹213.3m (up 68% from FY 2023). Profit margin: 3.6% (up from 2.1% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Annuncio • Apr 14
Aarti Surfactants Limited to Report Q4, 2024 Results on Apr 22, 2024 Aarti Surfactants Limited announced that they will report Q4, 2024 results on Apr 22, 2024 Buy Or Sell Opportunity • Apr 02
Now 21% overvalued Over the last 90 days, the stock has fallen 17% to ₹606. The fair value is estimated to be ₹501, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has declined by 7.8%. Reported Earnings • Jan 21
Third quarter 2024 earnings released: EPS: ₹8.42 (vs ₹5.25 in 3Q 2023) Third quarter 2024 results: EPS: ₹8.42 (up from ₹5.25 in 3Q 2023). Revenue: ₹1.39b (up 3.9% from 3Q 2023). Net income: ₹66.8m (up 68% from 3Q 2023). Profit margin: 4.8% (up from 3.0% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 7% per year. Annuncio • Jan 12
Aarti Surfactants Limited to Report Q3, 2024 Results on Jan 20, 2024 Aarti Surfactants Limited announced that they will report Q3, 2024 results at 4:00 PM, Indian Standard Time on Jan 20, 2024 Valuation Update With 7 Day Price Move • Dec 27
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹714, the stock trades at a trailing P/E ratio of 30.4x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 28% over the past three years. Reported Earnings • Nov 02
Second quarter 2024 earnings released: EPS: ₹5.97 (vs ₹0.43 in 2Q 2023) Second quarter 2024 results: EPS: ₹5.97 (up from ₹0.43 in 2Q 2023). Revenue: ₹1.44b (down 5.2% from 2Q 2023). Net income: ₹47.4m (up ₹44.2m from 2Q 2023). Profit margin: 3.3% (up from 0.2% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Annuncio • Oct 24
Aarti Surfactants Limited to Report Q2, 2024 Results on Oct 31, 2023 Aarti Surfactants Limited announced that they will report Q2, 2024 results on Oct 31, 2023 Annuncio • Aug 20
Aarti Surfactants Limited, Annual General Meeting, Sep 12, 2023 Aarti Surfactants Limited, Annual General Meeting, Sep 12, 2023, at 11:30 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2023 together with the Reports of the Board of Directors's and the Auditors's thereon; to appoint a director in place of Mr. Dattatray S. Galpalli, who retires by rotation and being eligible, offers himself for re-appointment; to re-appoint Mr. Mulesh M. Savla as an Independent Director; to approve revision in terms and conditions of appointment of Mr. Nikhil P. Desai Managing Director of the Company; to approve revision in terms and conditions of appointment of Mr. Santosh M. Kakade Executive Director of the Company; to create charge(s) on the properties of the Company, in respect of the borrowings; and to approve the remuneration of Cost Auditor for the Financial Year 2023-24. Reported Earnings • Jul 25
First quarter 2024 earnings released: EPS: ₹6.61 (vs ₹4.89 in 1Q 2023) First quarter 2024 results: EPS: ₹6.61 (up from ₹4.89 in 1Q 2023). Revenue: ₹1.49b (down 5.9% from 1Q 2023). Net income: ₹52.5m (up 42% from 1Q 2023). Profit margin: 3.5% (up from 2.3% in 1Q 2023). The increase in margin was driven by lower expenses. Annuncio • Jul 22
Aarti Surfactants Limited Appoints Priyanka Chaurasia as Company Secretary & Compliance Officer Aarti Surfactants Limited appointed Ms. Priyanka Chaurasia as Company Secretary & Compliance Officer, effective August 4, 2023. Annuncio • Jul 18
Aarti Surfactants Limited to Report Q1, 2024 Results on Jul 24, 2023 Aarti Surfactants Limited announced that they will report Q1, 2024 results on Jul 24, 2023 Reported Earnings • Apr 29
Full year 2023 earnings released: EPS: ₹16.64 (vs ₹7.25 in FY 2022) Full year 2023 results: EPS: ₹16.64 (up from ₹7.25 in FY 2022). Revenue: ₹6.02b (up 4.5% from FY 2022). Net income: ₹127.0m (up 131% from FY 2022). Profit margin: 2.1% (up from 1.0% in FY 2022). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Apr 28
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹686, the stock trades at a trailing P/E ratio of 56x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 11% over the past year. Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹571, the stock trades at a trailing P/E ratio of 46.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 38% over the past year. Reported Earnings • Feb 10
Third quarter 2023 earnings released: EPS: ₹5.25 (vs ₹2.94 loss in 3Q 2022) Third quarter 2023 results: EPS: ₹5.25 (up from ₹2.94 loss in 3Q 2022). Revenue: ₹1.34b (down 1.1% from 3Q 2022). Net income: ₹39.8m (up ₹62.1m from 3Q 2022). Profit margin: 3.0% (up from net loss in 3Q 2022). The move to profitability was driven by lower expenses. Annuncio • Feb 02
Aarti Surfactants Limited to Report Q3, 2023 Results on Feb 09, 2023 Aarti Surfactants Limited announced that they will report Q3, 2023 results at 12:08 PM, Indian Standard Time on Feb 09, 2023 Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Independent Director Misha Gala was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Nov 06
Second quarter 2023 earnings released: EPS: ₹0.43 (vs ₹1.10 in 2Q 2022) Second quarter 2023 results: EPS: ₹0.43 (down from ₹1.10 in 2Q 2022). Revenue: ₹1.52b (up 8.6% from 2Q 2022). Net income: ₹3.23m (down 61% from 2Q 2022). Profit margin: 0.2% (down from 0.6% in 2Q 2022). The decrease in margin was driven by higher expenses. Reported Earnings • Jul 15
Full year 2022 earnings released: EPS: ₹7.25 (vs ₹28.53 in FY 2021) Full year 2022 results: EPS: ₹7.25 (down from ₹28.53 in FY 2021). Revenue: ₹5.76b (up 24% from FY 2021). Net income: ₹54.9m (down 75% from FY 2021). Profit margin: 1.0% (down from 4.6% in FY 2021). The decrease in margin was driven by higher expenses. Reported Earnings • May 28
Full year 2022 earnings released: EPS: ₹7.24 (vs ₹28.53 in FY 2021) Full year 2022 results: EPS: ₹7.24 (down from ₹28.53 in FY 2021). Revenue: ₹5.76b (up 24% from FY 2021). Net income: ₹54.9m (down 75% from FY 2021). Profit margin: 1.0% (down from 4.6% in FY 2021). The decrease in margin was driven by higher expenses. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Misha Gala was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improved over the past week After last week's 17% share price gain to ₹883, the stock trades at a trailing P/E ratio of 71.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 22% over the past year. Reported Earnings • Feb 03
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: ₹2.94 loss per share (down from ₹6.30 profit in 3Q 2021). Revenue: ₹1.35b (up 27% from 3Q 2021). Net loss: ₹22.3m (down 147% from profit in 3Q 2021). Revenue was in line with analyst estimates. Valuation Update With 7 Day Price Move • Sep 14
Investor sentiment improved over the past week After last week's 17% share price gain to ₹1,640, the stock trades at a trailing P/E ratio of 49.5x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 205% over the past year. Valuation Update With 7 Day Price Move • Aug 04
Investor sentiment improved over the past week After last week's 15% share price gain to ₹1,702, the stock trades at a trailing P/E ratio of 54.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 562% over the past year. Reported Earnings • Jul 21
Full year 2021 earnings released: EPS ₹28.53 (vs ₹2.75 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹4.66b (up 43% from FY 2020). Net income: ₹216.3m (up ₹195.5m from FY 2020). Profit margin: 4.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Reported Earnings • May 23
Full year 2021 earnings released: EPS ₹28.52 (vs ₹2.75 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹4.66b (up 43% from FY 2020). Net income: ₹216.3m (up ₹195.4m from FY 2020). Profit margin: 4.6% (up from 0.6% in FY 2020). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improved over the past week After last week's 15% share price gain to ₹1,078, the stock trades at a trailing P/E ratio of 40.6x. Average trailing P/E is 17x in the Chemicals industry in India. Is New 90 Day High Low • Nov 06
New 90-day high: ₹587 The company is up 107% from its price of ₹284 on 07 August 2020. The Indian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. Is New 90 Day High Low • Oct 21
New 90-day high: ₹583 The company is up 74% from its price of ₹335 on 23 July 2020. The Indian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. 
